可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Drexler H, Fillkh M, Hoing S, et al. Systemic and regional vascular effects of atrial natriuretic peptide in a rat model of chronic heart failure[J]. Basic Res Cardiol, 1987, 82 (6) : 517.
[2] Amin DA, Shah PK. Swan-Ganz catheter: Insertion technique [J]. Jcritillness, 1986, 1 (4) : 38.
[3] 陈泮藻, 李振甲, 郝秀华, 等. 心钠素快速放射免疫分析[J]. 中华核医学杂志, 1986, 6 (3) : 147.
[4] Daridson MB, Barr MB, Struthers MD. C-type natriuretic peptide - an endogeous inhibitor of vascular angiotensin converting enzyme activity[J]. Circulation, 1996, 93 (6) : 1155.
[5] 许项立, 翁昌鸿, 任 吴, 等. 经皮二尖瓣成形术患者血浆心钠素和血管加压素水平的改变[J]. 中国循环杂志, 1994, 9 (12) :727.
[6] Nakamura M, Arakawa N, Abe Y, et al. Relationship between
plasma atrial natriuretic peptide concentration and atrial pressure in acute and chronic heart failure [J]. Jpn Heart J ,1990, 31 (4) : 425.